Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC)
This study, called Auto-COVID-VACC, is designed for adults in the UK who have weakened immune systems and are getting their COVID-19 vaccinations. Researchers want to understand how effectively these vaccines boost the body's defence against the virus. They will be taking extra blood samples at the same time as routine blood tests, so you won't need extra appointments or needle pokes for the study. By looking at these blood samples, scientists can learn more about how the immune system (specifically special cells called T and B cells) reacts to the vaccine. This information is really important for making sure people with weakened immune systems get the best possible protection from COVID-19.
At a glance
What is this study about?
This study, known as Auto-COVID-VACC, is looking into how well the COVID-19 vaccine works for people whose immune systems are not as strong as usual. These are often referred to as 'immunocompromised' individuals. The main goal is to understand how the body's defence system reacts to the vaccine. This involves studying special cells in the blood that fight off infections, to see how they respond after vaccination. The information from this study will help doctors and researchers understand if the current vaccination program provides enough protection for vulnerable people.
Taking part in this study means that when you go for your routine COVID-19 vaccination appointments, and if you already have blood taken for other health checks, the study will take an additional small blood sample at the same time. This means no extra visits to the clinic or additional uncomfortable procedures just for the study. Researchers will then analyse these blood samples to see how your body's immune cells, specifically T cells and B cells, react to the vaccine. These cells are key players in fighting off viruses like COVID-19.
This is an observational study, which means researchers are simply observing and collecting information while you receive your standard medical care. They are not giving you any new treatments or asking you to do anything different from your usual vaccination schedule. The aim is to gather valuable insights that can help improve vaccine strategies and protection for people with weakened immune systems in the future.
Key takeaways
- Study explores vaccine effectiveness in immunocompromised adults.
- No extra appointments or procedures are needed.
- Blood samples are drawn during routine care.
- Helps improve COVID-19 protection for vulnerable groups.
- You can withdraw from the study at any time.
Who may be eligible?
To join this study, you must be 18 years old or older. You also need to have a weakened immune system and be getting your COVID-19 vaccinations as recommended by health guidelines. Before you can join, you'll need to read and sign a consent form, which explains everything about the study in detail. This ensures you fully understand what's involved.
On the other hand, you can't take part if you haven't been vaccinated for COVID-19 according to the latest advice for people with weakened immune systems. Also, if you have tested positive for COVID-19 just before your first study visit, you wouldn't be able to join. The study is open to both men and women.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a weakened immune system?
- Are you receiving COVID-19 vaccinations according to current health guidelines?
- Have you tested negative for COVID-19 recently, if applicable?
- Are you willing to sign a consent form?
What does participation involve?
If you decide to take part in this study, your involvement will be very straightforward. You won't need to make any extra doctor's appointments or undergo any new medical procedures. The study will simply collect additional blood samples when you are already having blood drawn as part of your standard COVID-19 vaccination care or routine medical checks.
This means that at each stage where you normally receive your COVID-19 vaccine and have blood tests, a small extra sample will be taken from the same needle stick. These extra samples will be used to look at how your immune system is responding to the vaccine. You will continue to receive your vaccinations and medical care exactly as your doctor recommends. The total duration of your participation will depend on your vaccination schedule.
Potential risks and benefits
Locations (3)
- Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation (Med. Klinik IV) Uniklinik der RWTH AachenVerified postcodeAachen, Germany
- University Hospital of CologneVerified postcodeCologne, Germany
- Universitätsklinikum Essen Klinik für Hämatologie und StammzellentransplantationVerified postcodeEssen, Germany
Common questions
What is the main goal of this study?
The study aims to understand how well COVID-19 vaccines work in people with weakened immune systems by looking at their blood samples.
Do I need extra doctor's visits for this study?
No, you do not need any extra visits. Blood samples will be taken during your routine vaccination appointments or other scheduled blood tests.
Will taking part involve extra needles or pain?
No, an extra blood sample will be taken using the same needle stick used for your routine blood tests, so there won't be any additional pain or separate procedures.
Who can join this study?
Adults (18 or older) with weakened immune systems who are getting their COVID-19 vaccines according to standard guidelines can join.
Can I stop participating in the study if I change my mind?
Yes, you can leave the study at any time without it affecting your medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.